U.S. Markets open in 2 hrs 42 mins

ChromaDex Corporation (CDXC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.62-0.04 (-1.09%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close3.66
Bid2.60 x 1000
Ask0.00 x
Day's Range3.60 - 3.80
52 Week Range2.25 - 3.95
Avg. Volume417,209
Market Cap166.86M
PE Ratio (TTM)-26.23
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube10 days ago

    ETFs with exposure to Chromadex Corp. : June 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Chromadex Corp. Here are 5 ETFs with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Chromadex Corp. :CDXC-US: Earnings Analysis: Q1, 2017 By the Numbers : June 15, 2017
    Capital Cube11 days ago

    Chromadex Corp. :CDXC-US: Earnings Analysis: Q1, 2017 By the Numbers : June 15, 2017

    Categories: Yahoo FinanceGet free summary analysis Chromadex Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Chromadex Corp. – Natural Alternatives International, Inc., Albany Molecular Research, Inc., Opexa Therapeutics, Inc., Sangamo Therapeutics, Inc., Spherix Incorporated and Exelixis, Inc. (NAII-US, AMRI-US, OPXA-US, SGMO-US, SPEX-US and EXEL-US) ... Read more (Read more...)

  • Associated Press2 months ago

    ChromaDex reports 1Q loss

    The Irvine, California-based company said it had a loss of 5 cents per share. The natural products company posted revenue of $4.4 million in the period. In the final minutes of trading on Thursday, the ...